美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

F/m Emerald Life Sciences Innovation ETF

45.14

-0.9465-2.05%

盤後：45.350.2115+0.47%19:30 EDT

成交量：985

成交額：4.48萬

市值：1.24億

市盈率：- -

高：45.44

開：45.44

低：45.14

收：46.09

52周最高：48.78

52周最低：29.13

股本：275.70萬

流通股本：275.70萬

量比：0.41

換手率：0.04%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

重發-第4次更新-美國衞生部長小肯尼迪向關鍵衞生委員會增補了八名新成員

Cogent Biosciences宣佈FDA受理Bezuclastinib治療晚期系統性肥大細胞增多症的新藥申請

Guardant Health與Evernorth旗下Evicore達成協議，Shield血液檢測自2027年1月1日起納入結直腸癌篩查覆蓋範圍

阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LFSC"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":45.1385,"timestamp":1789761600000,"preClose":46.085,"halted":0,"volume":985,"hourTrading":{"tag":"盘后","latestPrice":45.35,"preClose":45.1385,"latestTime":"19:30 EDT","volume":9,"amount":406.2465,"timestamp":1789774205193,"change":0.2115,"changeRate":0.004686,"amplitude":0},"delay":0,"changeRate":-0.02053813605294565,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"休市中","change":-0.9465,"latestTime":"09-18 16:00:00 EDT","open":45.44,"high":45.44,"low":45.1385,"amount":44760.44289,"amplitude":0.006542,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":46.085,"sharesOutstanding":2657035,"nav":46.11,"aum":127587983.85,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":45.35,"preClose":45.1385,"latestTime":"19:30 EDT","volume":9,"amount":406.2465,"timestamp":1789774205193,"change":0.2115,"changeRate":0.004686,"amplitude":0},"volumeRatio":0.4080702474412452},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4080702474412452,"shares":2757035,"dividePrice":0,"high":45.44,"amplitude":0.006542,"preClose":46.085,"low":45.1385,"week52Low":29.13,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":45.1385,"eps":0,"divideRate":0,"volume":985,"delay":0,"ttmEps":0,"open":45.44,"prevYearClose":36.6147,"prevWeekClose":45.3275,"prevMonthClose":45.79,"prevQuarterClose":45.2033,"fiveDayClose":45.3275,"twentyDayClose":47.4404,"sixtyDayClose":43.2903},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668942109","title":"重發-第4次更新-美國衞生部長小肯尼迪向關鍵衞生委員會增補了八名新成員","url":"https://stock-news.laohu8.com/highlight/detail?id=2668942109","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668942109?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 03:56","pubTimestamp":1789674961,"startTime":"0","endTime":"0","summary":"小肯尼迪已对多个联邦卫生咨询机构进行了重组，包括疾病控制与预防中心的疫苗咨询委员会——他在去年解散整个委员会后，重新任命了其成员。美国最高法院去年6月作出的一项裁决 ，确认了小肯尼迪对预防保健委员会的管辖权。该裁决后的11月会议因2025年政府停摆而未能举行。今年5月，小肯尼迪解除了该有影响力的工作组主席和副主席的职务。路透联系美国卫生与公众服务部时，该部拒绝就专家小组下次会议的日期置评。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4S4591O0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","GNMX","LU0109394709.USD","FFOX","LU0320765992.SGD","BK4588","PTH","HELX","BK4585","GDOC","GNOM","LFSC","EKG","GH","LU0889565916.HKD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168602224","title":"Cogent Biosciences宣佈FDA受理Bezuclastinib治療晚期系統性肥大細胞增多症的新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1168602224","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168602224?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:01","pubTimestamp":1789473701,"startTime":"0","endTime":"0","summary":"Cogent Biosciences今日宣布，美国食品药品监督管理局已正式受理其针对Bezuclastinib的新药申请，该药物拟用于治疗晚期系统性肥大细胞增多症患者。因此，Cogent Biosciences此番取得的阶段性成果，无疑受到了医学界和投资圈的广泛关注。Bezuclastinib作为一种高选择性KIT D816V突变抑制剂，其设计初衷正是为了精准靶向驱动AdvSM等疾病的核心致病机制。随着NDA获得受理，后续的审评沟通及潜在的获批上市进程也将逐步展开，业界正持续跟踪该药物的监管动态与临床数据表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COGT","LFSC","BK4139","BK4505","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103100254","title":"Guardant Health與Evernorth旗下Evicore達成協議，Shield血液檢測自2027年1月1日起納入結直腸癌篩查覆蓋範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=1103100254","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103100254?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 04:08","pubTimestamp":1789416490,"startTime":"0","endTime":"0","summary":"Guardant Health公司宣布，Evernorth旗下的Evicore已决定将其Shield血液检测纳入结直肠癌（CRC）筛查的承保范围。这项覆盖计划将于2027年1月1日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GNMX","BK4588","LU0320765992.SGD","GH","LU0109394709.USD","HELX","GNOM","PTH","LU0889565916.HKD","BK4585","FFOX","LFSC","BK4551","GDOC","EKG","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2322448957.HKD","FTXH","MEDI","LU1992135399.USD","LU2272731865.HKD","XPH","MRNY","LFSC","PBE","IYH","IE00B5TLWC47.USD","BK4588","MRNX","LU2473716301.USD","HELX","IEHS","RXL","LU2272731600.USD","PBPH","TMED","WDNA","GNOM","FBT","BK4585","IBB","CANC","BIB","BIOY","LU2272731782.SGD","LU1992135472.HKD","PPH","BME","PSCH","BBH","RSPH","SBIO","IEIH","BBP","XBIX","IDNA","PJP","SYNB","IBRN","AZNH","LU2322448791.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LFSC\",params:#limit:6,delay:false,,,undefined,":[]}}